SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Infectious Diseases Referral — Florence Nightingale

PatientFlorence Nightingale
Date of birth1988-05-12
IdentifiersMRN HR-NI004-SYN; SSN (made up) 000-04-9271
Document date2026-03-02
AuthorIsobel Marchetti, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Suspected post-infectious ME/CFS in a 37-year-old nurse administrator who was treated for brucellosis abroad. Before we attribute her symptoms to ME/CFS, please assess for relapsed or focal brucellosis or another persisting infection. [S]

Urgency: Routine, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Nearly three years ago, while leading nurses at an overseas field hospital, she had a severe febrile illness with sweats and aches; a Brucella agglutination titer there was reported positive and she completed six weeks of doxycycline and rifampin, with the fever resolving. Since then she has had debilitating fatigue worsened by activity, post-exertional malaise lasting days, unrefreshing sleep, and cognitive difficulty, worse after an intense period of work last year. She is housebound most days. Today she is afebrile; a ten-minute standing test shows a heart rate rise of 26/min without hypotension. No spinal or joint tenderness and no liver or spleen enlargement. The NICE exclusion tests, including ESR and CRP, were drawn today [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a dayOne to two tablets by mouth every 6 hours as needed; no more than 3 g a dayOral route2025-11-03activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFSactiveconfirmed G93.32S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed.
Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapseactiveconfirmed Z86.19S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
May 1855Crimean fever at Balaclava: dangerously ill and near death, then a slow and painful recovery; she called it typhusD (CLM-0003)
May 1855Retrospective interpretation of the Crimean fever as brucellosis, without laboratory confirmation (possible, not established)R (CLM-0004)
August 1857Overwork and failing health during the army health commission, with rest at Malvern, a collapse with cardiac symptoms, then nausea, insomnia, and palpitations; took to her bed or couch on doctors' orders but kept workingD (CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-02Body height170cmS
2026-03-02Body weight55kgS
2026-03-02Body mass index (BMI) [Ratio]19kg/m2S
2026-03-02Systolic blood pressure104mm[Hg]S
2026-03-02Diastolic blood pressure66mm[Hg]S
2026-03-02Heart rate78/minS
2026-03-02Respiratory rate14/minS
2026-03-02Body temperature36.6CelS
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-02Hemoglobin [Mass/volume] in Blood12.9g/dL11.6-15 g/dLNormalS
2026-03-02Leukocytes [#/volume] in Blood by Automated count5.810*3/uL3.4-10.8 10*3/uLNormalS
2026-03-02Platelets [#/volume] in Blood by Automated count24610*3/uL150-450 10*3/uLNormalS
2026-03-02Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-03-02Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-03-02Creatinine [Mass/volume] in Serum or Plasma0.72mg/dL0.59-1.04 mg/dLNormalS
2026-03-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M110mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-02Glucose [Mass/volume] in Serum or Plasma86mg/dL70-99 mg/dLNormalS
2026-03-02Calcium [Mass/volume] in Serum or Plasma9.3mg/dL8.6-10.2 mg/dLNormalS
2026-03-02Albumin [Mass/volume] in Serum or Plasma4.3g/dL3.5-5.2 g/dLNormalS
2026-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma16U/L7-35 U/LNormalS
2026-03-02Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma19U/L10-35 U/LNormalS
2026-03-02Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma68U/L44-121 U/LNormalS
2026-03-02Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-03-02Phosphate [Mass/volume] in Serum or Plasma3.6mg/dL2.5-4.5 mg/dLNormalS
2026-03-02Erythrocyte [Sedimentation Rate] in Blood by Westergren method8mm/h<=20 mm/hNormalS
2026-03-02C reactive protein [Mass/volume] in Serum or Plasma1.2mg/L<=5 mg/LNormalS
2026-03-02Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-03-02Hemoglobin A1c/Hemoglobin.total in Blood5.1%<=5.6%NormalS
2026-03-02Ferritin [Mass/volume] in Serum or Plasma48ng/mL30-150 ng/mLNormalS
2026-03-02Tissue transglutaminase IgA Ab [Units/volume] in Serum1U/mL<=3.9 U/mLNormalS
2026-03-02Creatine kinase [Enzymatic activity/volume] in Serum or Plasma92U/L26-192 U/LNormalS
2026-03-02Cortisol [Mass/volume] in Serum or Plasma14.2ug/dL6.2-19.4 ug/dLNormalS
2026-03-02Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL232-1245 pg/mLNormalS
2026-03-02Folate [Mass/volume] in Serum or Plasma12.4ng/mL>=5.9 ng/mLNormalS
2026-03-0225-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma17ng/mL30-100 ng/mLLowS
2026-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-03-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
2026-03-02PROMIS fatigue - version 1.0 Tscore71{score}S
2026-03-02PROMIS physical function - version 1.0 Tscore32{score}S
2026-03-02Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S

Assessment

Plan of Treatment